BACKGROUND: Black women are disproportionately affected with triple-negative breast cancer and have relatively poor survival. To the authors' knowledge, it is not known to what extent differences in the clinical presentation of breast cancer between non-Hispanic white women and black women can be accounted for by the presence of mutations in the BRCA1 and BRCA2 genes. The authors sought to evaluate the frequency of BRCA pathogenic variants in a population-based sample of young black women with breast cancer. METHODS: Black women diagnosed with invasive breast cancer at age ≤50 years from 2009 to 2012 were recruited to the study through the Florida Cancer Registry. Participants underwent genetic counseling, completed a study questionnaire, and consented to release of their medical records. Saliva specimens were collected for BRCA sequencing and large rearrangement testing through multiplex ligation-dependent probe amplification. RESULTS: A DNA sample was evaluated for 396 women, 49 of whom (12.4%) had a mutation in BRCA1 or BRCA2. Eight recurrent mutations accounted for 49% of all pathogenic variants. CONCLUSIONS: To the authors' knowledge, the prevalence of BRCA mutations among the Florida-based sample of young black women with breast cancer in the current study exceeds that previously reported for non-Hispanic white women. It is appropriate to recommend BRCA testing in all young black women with invasive breast cancer.
BACKGROUND: Black women are disproportionately affected with triple-negative breast cancer and have relatively poor survival. To the authors' knowledge, it is not known to what extent differences in the clinical presentation of breast cancer between non-Hispanic whitewomen and black women can be accounted for by the presence of mutations in the BRCA1 and BRCA2 genes. The authors sought to evaluate the frequency of BRCA pathogenic variants in a population-based sample of young black women with breast cancer. METHODS: Black women diagnosed with invasive breast cancer at age ≤50 years from 2009 to 2012 were recruited to the study through the Florida Cancer Registry. Participants underwent genetic counseling, completed a study questionnaire, and consented to release of their medical records. Saliva specimens were collected for BRCA sequencing and large rearrangement testing through multiplex ligation-dependent probe amplification. RESULTS: A DNA sample was evaluated for 396 women, 49 of whom (12.4%) had a mutation in BRCA1 or BRCA2. Eight recurrent mutations accounted for 49% of all pathogenic variants. CONCLUSIONS: To the authors' knowledge, the prevalence of BRCA mutations among the Florida-based sample of young black women with breast cancer in the current study exceeds that previously reported for non-Hispanic whitewomen. It is appropriate to recommend BRCA testing in all young black women with invasive breast cancer.
Authors: Jing Zhang; James D Fackenthal; Yonglan Zheng; Dezheng Huo; Ningqi Hou; Qun Niu; Cecilia Zvosec; Temidayo O Ogundiran; Anselm J Hennis; Maria Cristina Leske; Barbara Nemesure; Suh-Yuh Wu; Olufunmilayo I Olopade Journal: Breast Cancer Res Treat Date: 2012-06-28 Impact factor: 4.872
Authors: M Trottier; J Lunn; R Butler; D Curling; T Turnquest; R Royer; M R Akbari; T Donenberg; J Hurley; S A Narod Journal: Clin Genet Date: 2014-09-06 Impact factor: 4.438
Authors: Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson Journal: Cancer Res Date: 2008-08-14 Impact factor: 12.701
Authors: Marie E Wood; Pamela Kadlubek; Trang H Pham; Dana S Wollins; Karen H Lu; Jeffrey N Weitzel; Michael N Neuss; Kevin S Hughes Journal: J Clin Oncol Date: 2014-02-03 Impact factor: 44.544
Authors: Michael J Hall; Julia E Reid; Lynn A Burbidge; Dmitry Pruss; Amie M Deffenbaugh; Cynthia Frye; Richard J Wenstrup; Brian E Ward; Thomas A Scholl; Walter W Noll Journal: Cancer Date: 2009-05-15 Impact factor: 6.860
Authors: S R Young; Robert T Pilarski; Talia Donenberg; Charles Shapiro; Lyn S Hammond; Judith Miller; Karen A Brooks; Stephanie Cohen; Beverly Tenenholz; Damini Desai; Inuk Zandvakili; Robert Royer; Song Li; Steven A Narod Journal: BMC Cancer Date: 2009-03-19 Impact factor: 4.430
Authors: Sharon E Plon; Diana M Eccles; Douglas Easton; William D Foulkes; Maurizio Genuardi; Marc S Greenblatt; Frans B L Hogervorst; Nicoline Hoogerbrugge; Amanda B Spurdle; Sean V Tavtigian Journal: Hum Mutat Date: 2008-11 Impact factor: 4.878
Authors: Claire C Conley; Brent J Small; Juliette Christie; Aasha I Hoogland; Bianca M Augusto; Jennifer D Garcia; Tuya Pal; Susan T Vadaparampil Journal: Psychooncology Date: 2020-05-11 Impact factor: 3.894
Authors: Anne Marie McCarthy; Mirar Bristol; Susan M Domchek; Peter W Groeneveld; Younji Kim; U Nkiru Motanya; Judy A Shea; Katrina Armstrong Journal: J Clin Oncol Date: 2016-05-09 Impact factor: 44.544
Authors: Babatunde Adedokun; Yonglan Zheng; Paul Ndom; Antony Gakwaya; Timothy Makumbi; Alicia Y Zhou; Toshio F Yoshimatsu; Alex Rodriguez; Ravi K Madduri; Ian T Foster; Aminah Sallam; Olufunmilayo I Olopade; Dezheng Huo Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-12-23 Impact factor: 4.254
Authors: Claire C Conley; Dana Ketcher; Maija Reblin; Monica L Kasting; Deborah Cragun; Jongphil Kim; Kimlin Tam Ashing; Cheryl L Knott; Chanita Hughes-Halbert; Tuya Pal; Susan T Vadaparampil Journal: J Genet Couns Date: 2020-01-07 Impact factor: 2.537
Authors: Claire C Conley; Jennifer D Garcia; Cristi Radford; Richard R Reich; Alvaro N Monteiro; Tuya Pal; Susan T Vadaparampil Journal: Breast J Date: 2020-04-22 Impact factor: 2.431
Authors: Priscila Barreto-Coelho; Danielle Cerbon; Matthew Schlumbrecht; Carlos M Parra; Judith Hurley; Sophia H L George Journal: Breast Cancer Res Treat Date: 2019-08-14 Impact factor: 4.872